Help keep Salon independent

Topic: Remdesivir

U.S. President Donald Trump's personal attorney Rudy Giuliani waits to testify before the Michigan House Oversight Committee on December 2, 2020 in Lansing, Michigan. (Rey Del Rio/Getty Images)

Giuliani's VIP COVID-19 treatment

Matthew Rozsa
U.S. President Donald Trump gestures upon return to the White House from Walter Reed National Military Medical Center on October 05, 2020 in Washington, DC. Trump spent three days hospitalized for coronavirus. (Win McNamee/Getty Images)

No, Trump wasn't "cured," scientists say

Matthew Rozsa
In this handout provided by The White House, President Donald Trump participates in a phone call with Vice President Mike Pence, Secretary of State Mike Pompeo, and Chairman of the Joint Chiefs of Staff Gen. Mark Milley in his conference room at Walter Reed National Military Medical Center on October 4, 2020 in Bethesda, Maryland. (Tia Dufour/The White House via Getty Images)

Inside Trump's VIP COVID treatment

Matthew Rozsa
A sign is posted in front of the Gilead Sciences headquarters on April 29, 2020, in Foster City, California. Gilead Sciences announced preliminary results of a drug trial with that showed at least 50% of patients with coronavirus that treated with a five-day dosage of Remdesivir improved and more than half were released from the hospital within two weeks. (Justin Sullivan/Getty Images)

AGs: end Gilead monopoly on COVID drug

Jake Johnson - Common Dreams
Advertisement:
Laura Ingraham goes after Remdesivir (Fox News)

Ingraham can't quit hydroxychloroquine

Igor Derysh
This photo taken Thursday, July 9, 2015, is the headquarters of Gilead Sciences in Foster City, Calif. Harvoni, the newest pill from California-based Gilead Sciences, accounted for more than three-fourths of the prescriptions filled for hepatitis-C drugs in the first three months of this year, according to IMS Health. (AP Photo/Eric Risberg)

We already paid for COVID-19 treatments

Alex Lawson - Independent Media Institute
Advertisement: